HY-100714-10mg
|
MedChemexpress LLC
|
DL-AP5 [CAS 76326-31-3]
|
|
COVID-19-immunoregulation
|
|
HY-100714-25mg
|
MedChemexpress LLC
|
DL-AP5 [CAS 76326-31-3]
|
|
COVID-19-immunoregulation
|
|
HY-100714-5mg
|
MedChemexpress LLC
|
DL-AP5 [CAS 76326-31-3]
|
|
COVID-19-immunoregulation
|
|
HY-100714-50mg
|
MedChemexpress LLC
|
DL-AP5 [CAS 76326-31-3]
|
|
COVID-19-immunoregulation
|
|
HY-101054-10mg
|
MedChemexpress LLC
|
NQ301 [CAS 130089-98-4]
|
|
COVID-19-immunoregulation
|
|
HY-101054-100mg
|
MedChemexpress LLC
|
NQ301 [CAS 130089-98-4]
|
|
COVID-19-immunoregulation
|
|
HY-101054-25mg
|
MedChemexpress LLC
|
NQ301 [CAS 130089-98-4]
|
|
COVID-19-immunoregulation
|
|
HY-101054-5mg
|
MedChemexpress LLC
|
NQ301 [CAS 130089-98-4]
|
|
COVID-19-immunoregulation
|
|
HY-101054-50mg
|
MedChemexpress LLC
|
NQ301 [CAS 130089-98-4]
|
|
COVID-19-immunoregulation
|
|
HY-101056-10mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
HY-101056-100mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
HY-101056-5mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
HY-101056-50mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
HY-103157-10mg
|
MedChemexpress LLC
|
PD146176 [CAS 4079-26-9]
|
|
COVID-19-immunoregulation
|
|
HY-103157-100mg
|
MedChemexpress LLC
|
PD146176 [CAS 4079-26-9]
|
|
COVID-19-immunoregulation
|
|
HY-103157-5mg
|
MedChemexpress LLC
|
PD146176 [CAS 4079-26-9]
|
|
COVID-19-immunoregulation
|
|
HY-103157-50mg
|
MedChemexpress LLC
|
PD146176 [CAS 4079-26-9]
|
|
COVID-19-immunoregulation
|
|
HY-108573-10mg
|
MedChemexpress LLC
|
P-1075 [CAS 60559-98-0]
|
|
COVID-19-immunoregulation
|
|
HY-108573-100mg
|
MedChemexpress LLC
|
P-1075 [CAS 60559-98-0]
|
|
COVID-19-immunoregulation
|
|
HY-108573-2mg
|
MedChemexpress LLC
|
P-1075 [CAS 60559-98-0]
|
|
COVID-19-immunoregulation
|
|
HY-108573-5mg
|
MedChemexpress LLC
|
P-1075 [CAS 60559-98-0]
|
|
COVID-19-immunoregulation
|
|
HY-108573-50mg
|
MedChemexpress LLC
|
P-1075 [CAS 60559-98-0]
|
|
COVID-19-immunoregulation
|
|
HY-108738-1mg
|
MedChemexpress LLC
|
Daclizumab [CAS 152923-56-3]
|
|
COVID-19-immunoregulation
|
|
HY-108738-10mg
|
MedChemexpress LLC
|
Daclizumab [CAS 152923-56-3]
|
|
COVID-19-immunoregulation
|
|
HY-108738-5mg
|
MedChemexpress LLC
|
Daclizumab [CAS 152923-56-3]
|
|
COVID-19-immunoregulation
|
|